Correction

Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: a cost effectiveness study

Maria Geitona¹ , Hara Kousoulakou² , Markos Ollandezos³ , Kostas Athanasakis³ , Sotiria Papanicolaou⁴ and Ioannis Kyriopoulos³

¹  Department of Economics, University of Thessaly, Magnissias 96, Dionyssos 14576, Greece

²  Institute for Economic and Industrial Research, Tsami Karatasi 11, 117 42 Athens, Greece

³  Department of Health Economics, National School of Public Health, Aleksandra's Avenue 196, 11521 Athens, Greece

⁴  Janssen-Cilag Pharmaceutical SACI, Eirinis Avenue 56, 15121 Pefki, Athens, Greece

author email corresponding author email

Annals of General Psychiatry 2009, 8:15doi:10.1186/1744-859X-8-15

The electronic version of this article is the complete one and can be found online at: http://www.annals-general-psychiatry.com/content/8/1/15

Received:	17 June 2009
Accepted:	18 June 2009
Published:	18 June 2009

© 2009 Geitona et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Correction to Geitona M, Kousoulakou H, Ollandezos M, Athanasakis K, Papanicolaou S and Kyriopoulos I: Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: a cost effectiveness study. Annals of General Psychiatry 2008, 7:16. This correction reports changes in the values listed for Ziprasidone and Aripiprazole in Table Ten.

Correction

Following the publication of our article [1], it has come to our attention that there was an error with the values listed for Ziprasidone and Aripiprazole in Table Ten. Table Ten should therefore appear as shown in this correction (Table 1).

References

1. Geitona M, Kousoulakou H, Ollandezos M, Athanasakis K, Papanicolaou S, Kyriopoulos I: Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: a cost effectiveness study.

   Annals of General Psychiatry 2008 , 7:16. PubMed Abstract | BioMed Central Full Text | PubMed Central Full Text

Have something to say? Post a comment on this article!